How effective is Prolia for Osteoporosis? (a real world drug study)
Summary:
Overall ratings: 3.1/5 Long term ratings: 3.2/5
This is a phase IV clinical study of how effective Prolia (denosumab) is for Osteoporosis and for what kind of people. The study is created by eHealthMe from 154 Prolia users and is updated continuously.
What is Prolia?
Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,388 Prolia users. Check the latest studies of Prolia.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,814 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.
154 people are studied for taking Prolia in Osteoporosis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Prolia effectiveness for Osteoporosis (number of people):
Overall:
- not at all: 14
- somewhat: 29
- moderate: 63
- high: 30
- very high: 18
Long Term:
- not at all: 3
- somewhat: 20
- moderate: 50
- high: 28
- very high: 12
Gender of people who take Prolia for Osteoporosis *:
- female: 90.91 %
- male: 9.09 %
Age of people who take Prolia for Osteoporosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 1.9500000000000002 %
- 40-49: 1.3 %
- 50-59: 11.69 %
- 60+: 85.06 %
Who find Prolia more effective for Osteoporosis?
Gender of people who take Prolia for Osteoporosis *:
- female: 97.92 %
- male: 2.08 %
Age of people who take Prolia for Osteoporosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 6.25 %
- 40-49: 4.17 %
- 50-59: 8.33 %
- 60+: 81.25 %
* Approximation only. Some reports may have incomplete information.
Do you take Prolia?
- You can start a phase IV clinical trial to monitor Prolia safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies
Alternative drugs to, pros and cons of:
- Prolia (151,388 reports)
Treatments, associated drugs and conditions:
- Osteoporosis (290,734 reports)
How the study uses the data?
The study is based on denosumab (the active ingredients of Prolia) and Prolia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Morphine Sulfate and Praluent - 15 seconds ago
- Drug interactions of Hydramine and Kitabis Pak - 17 seconds ago
- Could Benazepril Hydrochloride cause Chronic Kidney Disease? - 21 seconds ago
- Could Tazidime cause Otitis Media? - 24 seconds ago
- Could Rogaine cause Heart Rate Increased? - 26 seconds ago
- Could Tamsulosin Hydrochloride cause Hyponatremia? - 27 seconds ago
- Drug interactions of Duloxetine Hydrochloride and Acetazolamide - 29 seconds ago
- Could Ciclopirox cause Joint Swelling? - 31 seconds ago
- Drug interactions of Prednisolone Sodium Phosphate and Levothyroxine Sodium - 33 seconds ago
- Restless Leg Syndrome and Systemic Lupus Erythematosus - 39 seconds ago